Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision
Claus Cursiefen*,,
Lu Chen*,
Magali Saint-Geniez*,
Pedram Hamrah*,
Yiping Jin*,
Saadia Rashid*,
Bronislaw Pytowski,
Kris Persaud,
Yan Wu,
J. Wayne Streilein*,, and
Reza Dana*,¶
*Schepens Eye Research Institute and Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, 20 Staniford Street, Boston, MA 02114; Department of Ophthalmology, Friedrich-Alexander University Erlangen-Nürnberg, Schwabachanlage 6, 91054 Erlangen, Germany; and ImClone Systems, Inc., 180 Varick Street, New York, NY 10014
Edited by Judah Folkman, Harvard Medical School, Boston, MA, and approved June 9, 2006
Received for publication July 22, 2005.
Abstract:
Transparency of the cornea, the window of the eye, is a prerequisitefor vision. Angiogenesis into the normally avascular corneais incompatible with good vision and, therefore, the corneais one of the few tissues in the human body where avascularityis actively maintained. Here, we provide evidence for a criticalmechanism contributing to corneal avascularity. VEGF receptor3, normally present on lymphatic and proliferating blood vascularendothelium, is strongly constitutively expressed by cornealepithelium and is mechanistically responsible for suppressinginflammatory corneal angiogenesis.
Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity.
N. Singh, M. Tiem, R. Watkins, Y. K. Cho, Y. Wang, T. Olsen, H. Uehara, C. Mamalis, L. Luo, Z. Oakey, et al. (2013)
Blood
121, 4242-4249
|Abstract »|Full Text »|PDF »
Nerves and Neovessels Inhibit Each Other in the Cornea.
G. Ferrari, A. R. Hajrasouliha, Z. Sadrai, H. Ueno, S. K. Chauhan, and R. Dana (2013)
Invest. Ophthalmol. Vis. Sci.
54, 813-820
|Abstract »|Full Text »|PDF »
Klf4 Regulates the Expression of Slurp1, Which Functions as an Immunomodulatory Peptide in the Mouse Cornea.
S. Swamynathan, K.-A. Buela, P. Kinchington, K. L. Lathrop, H. Misawa, R. L. Hendricks, and S. K. Swamynathan (2012)
Invest. Ophthalmol. Vis. Sci.
53, 8433-8446
|Abstract »|Full Text »|PDF »
MicroRNA-31 targets FIH-1 to positively regulate corneal epithelial glycogen metabolism.
H. Peng, R. B. Hamanaka, J. Katsnelson, L.-L. Hao, W. Yang, N. S. Chandel, and R. M. Lavker (2012)
FASEB J
26, 3140-3147
|Abstract »|Full Text »|PDF »
Critical Role of TNF-{alpha}-Induced Macrophage VEGF and iNOS Production in the Experimental Corneal Neovascularization.
P. Lu, L. Li, G. Liu, T. Baba, Y. Ishida, M. Nosaka, T. Kondo, X. Zhang, and N. Mukaida (2012)
Invest. Ophthalmol. Vis. Sci.
53, 3516-3526
|Abstract »|Full Text »|PDF »
The Maintenance of Lymphatic Vessels in the Cornea Is Dependent on the Presence of Macrophages.
K. Maruyama, T. Nakazawa, C. Cursiefen, Y. Maruyama, N. Van Rooijen, P. A. D'Amore, and S. Kinoshita (2012)
Invest. Ophthalmol. Vis. Sci.
53, 3145-3153
|Abstract »|Full Text »|PDF »
Vascular Endothelial Growth Factor-C Promotes Alloimmunity by Amplifying Antigen-Presenting Cell Maturation and Lymphangiogenesis.
A. R. Hajrasouliha, T. Funaki, Z. Sadrai, T. Hattori, S. K. Chauhan, and R. Dana (2012)
Invest. Ophthalmol. Vis. Sci.
53, 1244-1250
|Abstract »|Full Text »|PDF »
Imaging and Evaluation of Corneal Vascularization Using Fluorescein and Indocyanine Green Angiography.
D. R. Anijeet, Y. Zheng, A. Tey, M. Hodson, H. Sueke, and S. B. Kaye (2012)
Invest. Ophthalmol. Vis. Sci.
53, 650-658
|Abstract »|Full Text »|PDF »
Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable.
C. Cursiefen, J. Colin, R. Dana, M. Diaz-Llopis, L. A. Faraj, S. Garcia-Delpech, G. Geerling, F. W. Price, L. Remeijer, B. T. Rouse, et al. (2012)
Br J Ophthalmol
96, 3-9
|Abstract »|Full Text »|PDF »
Pharmacologic Uncoupling of Angiogenesis and Inflammation during Initiation of Pathological Corneal Neovascularization.
J. M. Sivak, A. C. Ostriker, A. Woolfenden, J. Demirs, R. Cepeda, D. Long, K. Anderson, and B. Jaffee (2011)
J. Biol. Chem.
286, 44965-44975
|Abstract »|Full Text »|PDF »
VIP and Growth Factors in the Infected Cornea.
X. Jiang, S. A. McClellan, R. P. Barrett, E. A. Berger, Y. Zhang, and L. D. Hazlett (2011)
Invest. Ophthalmol. Vis. Sci.
52, 6154-6161
|Abstract »|Full Text »|PDF »
Blockade of Insulin Receptor Substrate-1 Inhibits Corneal Lymphangiogenesis.
D. Hos, B. Regenfuss, F. Bock, J. Onderka, and C. Cursiefen (2011)
Invest. Ophthalmol. Vis. Sci.
52, 5778-5785
|Abstract »|Full Text »|PDF »
Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes.
C. Cursiefen, K. Maruyama, F. Bock, D. Saban, Z. Sadrai, J. Lawler, R. Dana, and S. Masli (2011)
J. Exp. Med.
208, 1083-1092
|Abstract »|Full Text »|PDF »
Selective Activation of the Prostaglandin E2 Circuit in Chronic Injury-Induced Pathologic Angiogenesis.
E. L. Liclican, V. Nguyen, A. B. Sullivan, and K. Gronert (2010)
Invest. Ophthalmol. Vis. Sci.
51, 6311-6320
|Abstract »|Full Text »|PDF »
Intracellular Thiol Redox Status Regulates Lymphangiogenesis and Dictates Corneal Limbal Graft Survival.
A. Fukumoto, K. Maruyama, T. Walsh, K. Kajiya, J. Hamuro, P. A. D'Amore, and S. Kinoshita (2010)
Invest. Ophthalmol. Vis. Sci.
51, 2450-2458
|Abstract »|Full Text »|PDF »
Enhanced Experimental Corneal Neovascularization along with Aberrant Angiogenic Factor Expression in the Absence of IL-1 Receptor Antagonist.
P. Lu, L. Li, G. Liu, X. Zhang, and N. Mukaida (2009)
Invest. Ophthalmol. Vis. Sci.
50, 4761-4768
|Abstract »|Full Text »|PDF »
Safety Profile of Topical VEGF Neutralization at the Cornea.
F. Bock, J. Onderka, C. Rummelt, T. Dietrich, B. Bachmann, F. E. Kruse, U. Schlotzer-Schrehardt, and C. Cursiefen (2009)
Invest. Ophthalmol. Vis. Sci.
50, 2095-2102
|Abstract »|Full Text »|PDF »
C. Q. Yu, M. Zhang, K. I. Matis, C. Kim, and M. I. Rosenblatt (2008)
Invest. Ophthalmol. Vis. Sci.
49, 3870-3878
|Abstract »|Full Text »|PDF »
Inflammatory Corneal (Lymph)angiogenesis Is Blocked by VEGFR-Tyrosine Kinase Inhibitor ZK 261991, Resulting in Improved Graft Survival after Corneal Transplantation.
D. Hos, F. Bock, T. Dietrich, J. Onderka, F. E. Kruse, K.-H. Thierauch, and C. Cursiefen (2008)
Invest. Ophthalmol. Vis. Sci.
49, 1836-1842
|Abstract »|Full Text »|PDF »
VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes.
C. Halin, N. E. Tobler, B. Vigl, L. F. Brown, and M. Detmar (2007)
Blood
110, 3158-3167
|Abstract »|Full Text »|PDF »
Vascular endothelial growth factor-C stimulates the lymphatic pump by a VEGF receptor-3-dependent mechanism.
J. W. Breslin, N. Gaudreault, K. D. Watson, R. Reynoso, S. Y. Yuan, and M. H. Wu (2007)
Am J Physiol Heart Circ Physiol
293, H709-H718
|Abstract »|Full Text »|PDF »